COMMUNIQUÉS West-GlobeNewswire

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
20/05/2026
Conference call and webcast to discuss results to be held on June 22, 2026 at 8 a.m. ET IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/05/2026
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Johns Hopkins Health Plans Awards $60,000 to Maryland and Virginia Organizations
20/05/2026
Corporate Giving Program Supports Nonprofits Addressing Food Insecurity, Healthy Aging and Child Advocacy HANOVER, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans has announced new recipients of its [...]
Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026
20/05/2026
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Nanobiotix annonce le lancement d’une offre globale
21/05/2026
Paris, France ; Cambridge, Massachusetts (USA), 20 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – « Nanobiotix » ou la « Société »), une société de biotechnologie au stade clinique et en phase [...]
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
BOSTON and SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
LeMaitre to Participate at Upcoming Investor Conferences in June
20/05/2026
BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June. Jefferies Global Healthcare [...]
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
20/05/2026
MIAMI, May 20, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today [...]
Information on the total number of voting rights and shares
20/05/2026
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), May 20, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
20/05/2026
Jupiter, FL, May 20, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous system disorders and [...]
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
20/05/2026
OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”, today announced that it has entered into definitive agreements for a registered direct offering priced at- [...]
FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products
20/05/2026
Agency takes action to combat unauthorized tobacco products resembling candy, breath strips, and cough drops Silver Spring, MD, May 20, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration announced today that [...]
How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime
20/05/2026
Testo Prime Launched Safe and Natural Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Read User Guide to Best Result For Energy, Stamina and Performance New York City, May 20, 2026 (GLOBE NEWSWIRE) -- IN [...]
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
20/05/2026
agenT-797 demonstrates pathogen suppression, lung immune restoration and tissue repair activation, supporting Ongoing Phase 2 trial Sequential immunotherapy with agenT-797 and N-803, an FDA-approved IL-15 superagonist, [...]
Ronald McDonald House New England Launches Brand Revitalization, Deepening its Mission to Keep Families Close
20/05/2026
Alongside a national brand modernization effort, Ronald McDonald House New England is preparing to embark on a bold new chapter—one that will meaningfully expand their ability to support families navigating pediatric [...]
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
20/05/2026
BioStem Technologies Expands Global Placental Allograft Patent Portfolio Pompano Beach, FL, May 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies®, a leading regenerative medicine company focused on developing and [...]
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
20/05/2026
PETACH TIKVA, Israel, May 20, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment [...]
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
20/05/2026
Discussion highlights significant unmet need in ovarian cancer and the potential of ERNA-101 to address limitations of current therapies Segment also discusses evolving treatment landscape, immunologically “cold” tumors [...]
Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
20/05/2026
Company Generated $22.3 Million of Operating Income and Reported $552.4 Million of GAAP Net Income, Including Significant Non-Cash Warrant-Related Gains Company Held Approximately 2.15 Billion SKY Tokens at March 31, [...]

Pages